John D. Bluth
Public Communications Contact presso BIOCRYST PHARMACEUTICALS, INC.
Profilo
John D.
Bluth is currently the Chief Communications Officer at BioCryst Pharmaceuticals, Inc. Prior to his current position, he held the role of Director-Investor Relations at CV Therapeutics, Inc. From 2012 to 2016, he served as the SVP-Investor Relations & Corporate Communications at PowerSecure International, Inc. He also held the positions of EVP-Investor Relations & Corporate Communications at both Cempra, Inc. and Melinta Therapeutics, Inc. Before that, from 2009 to 2012, he was the SVP-Investor Relations & Group Communications at Elster Group SE.
Mr. Bluth completed his undergraduate degree at Cornell University.
Posizioni attive di John D. Bluth
Società | Posizione | Inizio |
---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Public Communications Contact | 01/04/2019 |
Precedenti posizioni note di John D. Bluth
Società | Posizione | Fine |
---|---|---|
MELINTA THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 31/12/2017 |
POWERSECURE INTERNATIONAL, INC. | Contatto Relazioni con gli Investitori | 01/01/2016 |
Elster Group SE
Elster Group SE Industrial MachineryProducer Manufacturing Elster Group SE provided electricity, gas and water measurement and control services. The firm offered distribution monitoring and control, advanced smart metering, demand response, networking and software solutions, and related communications and services. The company was founded on October 4, 2004 and was headquartered in Mainz-Kastel, Germany. | Contatto Relazioni con gli Investitori | 01/01/2012 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Contatto Relazioni con gli Investitori | 02/05/2011 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Contatto Relazioni con gli Investitori | - |
Formazione di John D. Bluth
Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Elster Group SE
Elster Group SE Industrial MachineryProducer Manufacturing Elster Group SE provided electricity, gas and water measurement and control services. The firm offered distribution monitoring and control, advanced smart metering, demand response, networking and software solutions, and related communications and services. The company was founded on October 4, 2004 and was headquartered in Mainz-Kastel, Germany. | Producer Manufacturing |
PowerSecure International, Inc.
PowerSecure International, Inc. Electrical ProductsProducer Manufacturing PowerSecure International, Inc. engages in the business of providing energy technologies and services to electric utilities and large industrial, commercial, institutional and municipal customers. It provides products and services through four reporting segments: distributed generation, solar energy, utility infrastructure, and energy efficiency. The company was founded by Sidney Hinton on April 5, 1991 and is headquartered in Wake Forest, NC. | Producer Manufacturing |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
- Borsa valori
- Insiders
- John D. Bluth